NewsDemecan On-Track To Hit Early 2022 Harvest After Fund-Raising...

Demecan On-Track To Hit Early 2022 Harvest After Fund-Raising Boost

-

GERMANY’s sole domestic cannabis producer is expected to harvest its first crop in early 2022 after securing additional investment to complete its production facility.

Demecan, which was founded in 2017, is one of three companies permitted to cultivate cannabis in Germany by the Federal Institute for Drugs and Medical Devices. 

Some 4,000 cannabis plants will be sowed in October at its new facility near Dresden, with the first products to be delivered early next year.

This follows a successful fund-raising round – in the ‘upper single-digit million range’ – from private and institutional investors, including the Futury Fund as well as existing shareholders, including the btov Private Investor Network.

Harvest As Quickly As Possible

Dr Constantin von der Groeben, Co-Founder and CEO of Demecan, told BusinessCann: “The investment is to used for further growth as well as the expansion of the production facility into Europe’s most modern facility for the cultivation and processing of medicinal cannabis.

“Under current conditions, Demecan plans to complete the manufacturing facility in the third quarter of 2021 and harvest as quickly as possible.”

Demecan is converting a former slaughterhouse on an 100,000 sq ms plot of land into an indoor production facility with office space and a laboratory. 

Demecan’s cultivation facilities in Ebersbach, South East Germany

The halls are currently under construction with the installation of air filter systems, water tanks and around 150 video cameras.

When sowed 1,000 plants will grow in each of the four halls. The labour-intensive operation is expected to initially employ around 80 people.

Initially, Demecan aims to harvest up to one tonne of cannabis and its three founders believe that as the German market grows it will move towards its capacity of around 10 tonnes per year.

Last month Canadian company Tilray became the first of the three producers to deliver homegrown flower in to the market through its subsidiary Aphria. The third supplier is fellow Canadian company Aurora

Seven Million Euros

The Federal Institute’s total permitted cultivation amount is 10.4 tonnes of medicinal cannabis over four years. 

In April this year Demecan closed its latest multi-million Euro financing round, with Dr Adrian Fischer, physician, co-founder, and CEO saying: “It is Demecan’s mission to guarantee the nationwide supply of high-quality medical cannabis for the benefit of patients in Germany. 

“Therefore, we not only focus on the cultivation of medical cannabis but are also active in the field of R&D to develop new and innovative dosage forms.”

Demecan says it intends to establish a subsidiary in the state of Hessen with the aim of establishing a dedicated medical cannabis research cluster.

In 2019, the Berlin startup has received seven million euros in a Series A financing round

Half of the investment came from the private investor network of the European venture capitalist btov Partners. The other half came from a German entrepreneurial family. 

Main Image: Dr. Adrian Fischer, Dr. Cornelius Maurer and Dr. Constantin von der Groeben (from left to right).

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover...

Columbia Care Platinum Joins Forces With Poppy Jamie

Leading organic, vegan and regeneratively-farmed, plant-based CBD brand, Columbia Care Platinum(www.shop.col-care.uk), announces it has teamed up with Poppy Jamie, mental wellbeing...

InterCure Announces European Expansion with International Cannabis Brand Cookies

InterCure Ltd. today announced its international expansion into Europe through a partnership with iconic cannabis brand Cookies. The parties entered...

Groups From 56 Countries Ask UN To Ensure Secretive ‘Cannabis Initiative’ Is Open To Public Scrutiny

ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy...

The New Common Agricultural Policy Has Been Adopted And the Maximum THC Level on the Field Has Been Restored to 0.3%

It was in October 2020 when we announced that the European Parliament had voted in favour of restoring the...

European Medical Cannabis Tech Accelerator Opens Call for Submissions

The first and only hybrid tech accelerator in Europe dedicated to the medical cannabis industry offers €100,000 grant to early-stage startups from around the world.

Must read

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior...

You might also likeRELATED
Recommended to you